The aim of the British Society for Gene and Cell Therapy is to accelerate scientific progress and promote ethical and efficient transfer of gene- and cell-based technologies from the laboratory into the clinic.
Gene and cell therapy is an area where co-operation between ALL the interested parties – general public, patients, scientists, government and the media – is vital for the optimal development of these technologies and treatments, and BSGCT is working towards becoming this pro-active interface.
The latest news from BSGCT
Upcoming events and activities
Check out our blog posts!
British Society for Gene and Cell Therapy
Create a secure account Forgotten your details?
The RCI - Regensburg Centre for Interventional Immunology (foundation public law) researches and develops new immunotherapies for the treatment of tumours, autoimmune diseases and transplant rejections. The Chair for Genetic Immunotherapy at the RCI, Prof. Dr. Hinrich Abken, is recruiting a Post-doctoral Scientist in “CAR redirected T cells”
ERC Horizon Europe 2021 funding calls open. View the work programme and calendar for grant competitions.
